Log in

Chemcon Speciality Chemicals

NSE: CHEMCON · ISIN INE03YM01018 · Basic Materials

₹194.00−1.15 (−0.59%)

Monday 9 November, 13:27 IST. Delayed. Source: Yahoo Finance.

Price chart

₹194.00 −1.15 (−0.59%) today

The day

Previous close
₹195.15
Open
₹195.99
Day high
₹197.99
Day low
₹191.14

Listed on NSE since 1 October 2020.

Key numbers

Market value
₹710.64 Cr
P/E (trailing)
24.22
EPS (trailing)
₹8.01
Price to book
1.49
Dividend yield
6.66%
Return on equity
6.0%
Debt to equity
0.06
Profit margin
11.3%
Beta
0.38
Volume today
16,015
Average volume
40,300

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹301.24 Cr₹55.11 Cr₹15.04
FY24₹265.46 Cr₹19.19 Cr₹5.24
FY25₹206.11 Cr₹24.45 Cr₹6.68
FY26₹239.09 Cr₹23.60 Cr₹6.44

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹65 Cr₹8 Cr₹2.05+30.8%
Q1 FY27Apr–Jun 2026₹66 Cr₹11 Cr₹2.99+71.6%
Q4 FY26Jan–Mar 2026Audited₹75 Cr₹6 Cr₹1.74+61.5%
Q3 FY26Oct–Dec 2025₹57 Cr₹5 Cr₹1.39–
Q2 FY26Jul–Sep 2025₹54 Cr₹6 Cr₹1.57–
Q1 FY26Apr–Jun 2025₹54 Cr₹6 Cr₹1.74–

Source: Chemcon Speciality Chemicals’s results filed with NSE, standalone (the company alone). Net profit is the share of Chemcon Speciality Chemicals’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹211 Cr₹216 Cr₹191 Cr
Investments₹11 Cr₹10 Cr₹11 Cr
Inventories₹65 Cr₹67 Cr₹76 Cr
Owed by customers₹42 Cr₹64 Cr₹58 Cr
Cash and equivalents₹11 Cr₹10 Cr₹19 Cr
Total assets₹538 Cr₹568 Cr₹548 Cr
Borrowings₹27 Cr₹53 Cr₹26.16 L
Total liabilities₹60 Cr₹85 Cr₹35 Cr
Shareholders’ equity₹478 Cr₹483 Cr₹513 Cr

Source: Chemcon Speciality Chemicals’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

About Chemcon Speciality Chemicals

Chemcon Speciality Chemicals Limited engages in the manufacture and sale of specialty chemicals for pharmaceutical, agro-chemical, textile, personal care, construction, automotive, electronics, aromatic chemicals, fine chemical, silanes, and oilfield chemicals industries in India and internationally. The company offers oilfield chemicals, including calcium bromide liquid, calcium bromide powder, sodium bromide solution, and zinc bromide solution; pharmaceutical chemicals, such as hexamethyl disilazane, trimethyl chlorosilane, hexamethyl disiloxane, bromobenzene, dibromomethane, and chloromethyl isopropyl carbonate; silanes comprising hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane; agro chemicals, including bromobenzene, ammonium chloride, and dibromomethane; and fragrance chemicals. The company also provides contract development and manufacturing services. The company was incorporated in 1988 and is based in Vadodara, India.

Industry
Specialty Chemicals
Based in
Vadodara
Employees
238

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Chemcon Speciality Chemicals in the last day or two.

Dividends and corporate actions

All companies
  • Interim Dividend - Rs 6.50 Per Share

    Dividend · ex-date 27 May 2026 · record date 28 May 2026

  • Interim Dividend - Rs 4 Per Share

    Dividend · ex-date 22 August 2022 · record date 23 August 2022

  • Annual General Meeting

    Action · ex-date 18 July 2022 · record date 19 July 2022

  • Annual General Meeting

    Action · ex-date 20 September 2021

Source: NSE. Latest first.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.